DOX-TPP
biotech grade
Reagent
Code: #97022
blur_circular Chemical Specifications
inventory_2
Storage & Handling
Storage
2-8℃
description Product Description
DOX-TPP is primarily utilized in the field of targeted drug delivery, especially in cancer therapy. It combines the chemotherapeutic agent doxorubicin (DOX) with a mitochondrial-targeting ligand, triphenylphosphonium (TPP), to enhance the precision of drug delivery. This conjugate is designed to specifically target cancer cell mitochondria, where it can induce apoptosis more effectively. By concentrating the drug within the mitochondria, DOX-TPP minimizes damage to healthy cells, reducing side effects commonly associated with traditional chemotherapy. Its application is particularly promising in treating resistant cancers, as it overcomes some of the limitations of conventional treatments by improving cellular uptake and therapeutic efficacy.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Solid |
| Substitution | 95-100% |
| 1H NMR | Identical to the Structure |
| Infrared Spectrum | Conforms to Structure |
| Foreign Material | None |
shopping_cart Available Sizes & Pricing
Cart
No products
Subtotal:
0.00
Total
0.00
THB